Wouldn't matter whether the Varmo deal is a dud, or is diminished in its revenue size. Its small bikkies compared with the potential of CannEpil and other treatments under research for a whole range of health issues. Having said that I consider that the BOD's have not done enough due diligence on the certainty of payment from Varm Cosmo. It probably will arrive eventually but the BOD need to learn to stop making overly positive claims well before deals are sealed and locked away.
Today's Trade, page-473
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
